Transgenic selection and underlying mechanisms in apicomplexan parasites

Area of Science:

• Parasitology
• Molecular Biology
• Genetic Engineering

Background:

• Apicomplexan parasites pose significant global health challenges.
• Genetic engineering is crucial for understanding and controlling these pathogens.
• Selectable markers are essential tools for generating genetically modified apicomplexans.

Purpose of the Study:

• To review three decades of progress in apicomplexan transgenics enabled by selectable markers.
• To provide practical guidance on using and troubleshooting selectable markers in parasite engineering.
• To outline future directions for expanding the toolkit of selection strategies.

Main Methods:

• Consolidation of progress across model apicomplexan parasites (Toxoplasma, Plasmodium, Cryptosporidium, etc.).
• Dissection of positive and negative drug selection mechanisms and marker recycling.
• Integration of practical guidance, failure diagnostics, and future strategies.

Main Results:

• Selectable markers have been instrumental in enabling genome engineering in diverse apicomplexan species.
• Established methods for positive and negative drug selection, along with marker recycling, are detailed.
• New strategies including auxotrophy, orthogonal resistance genes, and CRISPR-based editing are proposed.

Conclusions:

• Selectable markers provide a robust framework for apicomplexan parasite engineering.
• Future research should focus on orthogonal, host-sparing selection strategies for broader applications.
• Advancements in marker systems are critical for vaccine development and pathway-scale engineering.